Literature for peptidase S01.034: transmembrane peptidase, serine 4

(References are filtered for relevance to Inhibitor. To remove the filter click here. See explanation.)

2017
1. Seo,B.R., Min,K.J., Woo,S.M., Choe,M., Choi,K.S., Lee,Y.K., Yoon,G. and Kwon,T.K.
   Inhibition of cathepsin S induces mitochondrial ROS that sensitizes TRAIL-mediated apoptosis through p53-mediated downregulation of Bcl-2 and c-FLIP
   Antioxid Redox Signal27, 215-233. PubMed  Europe PubMed DOI  I
2. Tanabe,L.M. and List,K.
   The role of type II transmembrane serine protease-mediated signaling in cancer
   FEBS J284, 1421-1436. PubMed  Europe PubMed DOI  I
2016
3. Ilamathi,M., Hemanth,R., Nishanth,S. and Sivaramakrishnan,V.
   Identification of potential transmembrane protease serine 4 inhibitors as anti-cancer agents by integrated computational approach
   J Theor Biol389, 253-262. PubMed  Europe PubMed DOI  T  I
2013
4. Kang,S., Min,H.J., Kang,M.S., Jung,M.G. and Kim,S.
   Discovery of novel 2-hydroxydiarylamide derivatives as TMPRSS4 inhibitors
   Bioorg Med Chem Lett23, 1748-1751. PubMed  Europe PubMed DOI  I